← Leaderboards
Lesley M Butler
University Of California Davis
$1,522,274
Attributed
$1,522,274
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $506.9K · FY2012–14$1M$750K$500K$250K$0
'12
'13
'14
Funding mix
By agency
NIH$1,522,274 · 3
By mechanism
R01$1,287,970 · 1
R03$234,304 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Davis
Same institution · by research overlap
- Earl E Carstens$7,545,843
- Tilahun D Yilma$5,862,063
- Fredric A Gorin$2,626,480
- Paulo H. Verardi$3,754,968
Others in their field
Top investigators on “Cancer Risk”
- Gregory H Reaman · National Childhood Cancer Foundation$242,495,090
- David Heimbrook · Leidos Biomedical Research, Inc.$222,048,828
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$144,085,463
- Mitchell D Schnall · University Of Pennsylvania$138,156,012
- Peter C Adamson · National Childhood Cancer Foundation$128,266,602
Research focus
Cancer RiskPopulation BasedBaseMatrix MetalloproteinasesMortality Vital StatisticsPhenotypeEnzymesEventIn SituMalignant NeoplasmsBiochemicalMetalloproteasesNested Case-Control StudyCancer DiagnosisGelatinase ACohortEvaluationMemberDiagnosticGelatinase BDiagnosisIn VivoChinese PeopleProspective
Grant awards (6)
Urinary matrix metalloproteinases and breast cancer risk in a prospective cohort$428,373
R01 · FY2014 · CA · contact PI
Urinary metalloproteinases and ovarian cancer risk in a prospective cohort$78,537
R03 · FY2014 · CA · contact PI
Urinary matrix metalloproteinases and breast cancer risk in a prospective cohort$405,686
R01 · FY2013 · CA · contact PI
Urinary metalloproteinases and ovarian cancer risk in a prospective cohort$93,703
R03 · FY2013 · CA · contact PI
Urinary matrix metalloproteinases and breast cancer risk in a prospective cohort$453,911
R01 · FY2012 · CA · contact PI
Cancer Incidence among Transplant Recipients:1990-2001$62,064
R03 · FY2004 · CA